Results 201 to 210 of about 3,547,224 (332)
Structural, Superconducting and Magnetic Properties of Oxygen‐Annealed Fe1+yTe Thin Films
FeTe:Ox films exhibit exchange bias below their Néel temperatures, which coexists with superconductivity. STEM analysis reveals the structural changes induced by oxygen treatment. DFT calculations indicate that interstitial oxygen suppresses antiferromagnetism and promotes superconductivity.
Miao Meng +15 more
wiley +1 more source
The LHCb Stripping Project: Sustainable Legacy Data Processing for High-Energy Physics. [PDF]
Grieser NA +5 more
europepmc +1 more source
Rational Design of Donor‐Acceptor Oligomers for Enhanced Charge Separation
How can molecular symmetry be broken to maximize photoinduced charge separation? Through first‐principles analysis of 22 DTP‐based donor‐acceptor ternary oligomers, this work establishes that combining architectural asymmetry with site‐selective acceptor fluorination creates an ideal electrostatic landscape for frontier orbital segregation.
Jannik Theile +3 more
wiley +1 more source
Portable Raspberry Pi Platform for Automated Interpretation of Lateral Flow Strip Tests. [PDF]
Nakou N, Tsikas PK, Kalogianni DP.
europepmc +1 more source
Objective The phase 3 MANDARA study demonstrated noninferiority of benralizumab versus mepolizumab for remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). More benralizumab‐treated patients achieved complete withdrawal of oral glucocorticoids (OGCs).
Parameswaran K. Nair +14 more
wiley +1 more source
A Codesign Framework for the Development of Next Generation Wearable Computing Systems. [PDF]
Porreca F, Frustaci F, Gravina R.
europepmc +1 more source
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami +10 more
wiley +1 more source
Development and efficacy testing of an artificial intelligence enabled treatment package (eDOSTHI) for tobacco cessation: study protocol for a randomized controlled trial. [PDF]
Mukhopadhyay K +15 more
europepmc +1 more source

